Plenty of examples out there of senior execs and management staff resigning. I could not imagine she left any other way than this. If it was not material, then her appointment was not material either and why release it?
For what its worth, I wish her well in her future endevours and thank her for her contribution to the company.
Seems POH are not concerned or unphased that the CEO and COO positions are vacant, or the comfortable board or its devoted sh. So be it. POH is not all rosey and has its fair share of conjecture.
No bee in my bonnet as you put it. Just want clarity. Some of the annoucements released tend to provide more questions than answers imo.
When do you think the oxymorphone and oxycodone programs will advance? Who is going to design the clinical trials?
Do i smell another delay? Or will the peanut gallery accept this because we had a tough 2013. Its ok, we'lllget there in the end.
Plenty of examples out there of senior execs and management...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 40962233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39705430 | 30 |
View Market Depth
| Last trade - 10.00am 15/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable